Mandate

Vinge advises Anyfin in a capital procurement of SEK 450 million

October 05, 2021 M&A

The new financing will be used for future internationalization, among other things, in conjunction with the company’s launch in Germany, and for future investments in technology and in order to broaden the product offering.

Anyfin helps its customers to reduce their interest costs by refinancing original loans and providing better offers in respect of the customers’ loans.

Vinge’s team primarily consisted of Johan LarssonCarl SanderEllinor WargenbrantStina Bengtsson and Eléonore Friberg.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025